Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
PETROCHINA
00857
CN Stock MarketDetailed Quotes
Beijing Wantai Biological Pharmacy Enterprise (603392)
- 35.51
- -0.87-2.39%
Not Open Jun 2 15:00 CST
44.90BMarket Cap-115.67P/E (TTM)
36.30High35.30Low32.59KlotVolume36.30Open36.38Prev Close116.19MTurnover0.26%Turnover RatioLossP/E (Static)1.26BShares71.5952wk High3.80P/B44.90BFloat Cap33.0252wk Low40.02Limit Up1.26BShs Float146.57Historical High32.74Limit Down2.75%Range %3.21Historical Low--Dividend TTM35.65Avg Price15.73KlotAsk--Div Yield TTM100Lot Size14.98KlotBid
Beijing Wantai Biological Pharmacy Enterprise (603392) Balance Sheet
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 25.85%2.36B | 1.96%2.43B | -7.65%2.34B | -40.63%1.78B | -50.25%1.87B | -37.46%2.39B | -30.94%2.53B | -19.18%3B | -13.80%3.77B | -26.46%3.82B |
| Transactional financial assets | -21.27%1.6B | -42.35%1.45B | -33.59%1.54B | -4.57%2.07B | -1.38%2.03B | 22.12%2.51B | 13.13%2.32B | -2.38%2.17B | -2.37%2.06B | 2.33%2.06B |
| Notes receivable and accounts receivable | -20.08%1.51B | -20.52%1.63B | -29.07%1.74B | -31.52%1.78B | -33.98%1.89B | -31.74%2.04B | -38.37%2.45B | -44.00%2.61B | -44.46%2.86B | -24.12%3B |
| -Notes receivable | 116.04%9.22M | 107.50%8.69M | 81.65%7.57M | 10.18%4.49M | 119.76%4.27M | -9.18%4.19M | 29.97%4.17M | -24.35%4.08M | -57.92%1.94M | -42.71%4.61M |
| -Accounts receivable | -20.39%1.5B | -20.79%1.62B | -29.26%1.73B | -31.59%1.78B | -34.09%1.89B | -31.77%2.04B | -38.43%2.45B | -44.02%2.6B | -44.45%2.86B | -24.08%2.99B |
| Other receivables (including interest and dividends) | -62.01%18.48M | -27.39%9.71M | 476.47%156.62M | 177.87%65.68M | 116.87%48.65M | -19.01%13.37M | -28.75%27.17M | -25.10%23.64M | 85.41%22.44M | 54.36%16.5M |
| -Other receivable | ---- | ---- | ---- | 177.87%65.68M | ---- | -19.01%13.37M | ---- | -25.10%23.64M | ---- | 54.36%16.5M |
| Advance payment | 269.89%80.04M | 69.86%22.39M | 55.24%31.3M | 22.86%27.68M | 52.13%21.64M | 7.39%13.18M | 17.63%20.16M | -31.48%22.53M | -54.48%14.22M | -62.53%12.28M |
| Inventories | -20.25%767.06M | -18.67%702.08M | -1.77%831.26M | 13.77%947M | 12.62%961.77M | -4.67%863.19M | -24.55%846.24M | -23.11%832.35M | -14.91%853.99M | 4.18%905.48M |
| Receivable financing | 25.52%17.05M | -33.44%12.64M | 20.38%17.42M | 64.84%19.44M | 16.01%13.59M | 445.59%19M | 231.40%14.47M | -60.67%11.79M | 47.08%11.71M | -72.02%3.48M |
| Non-current assets due within one year | -51.67%348M | 143.33%1.17B | 92.31%1.25B | 157.78%1.16B | 140.00%720M | 20.00%480M | 550.00%650M | 350.00%450M | 200.00%300M | --400M |
| Other current assets | -54.72%29.65M | 140.16%104.22M | -30.76%89.17M | -42.34%50.08M | -25.88%65.48M | -54.39%43.4M | 119.49%128.79M | -29.96%86.85M | -31.00%88.34M | -10.49%95.15M |
| Adjustment items of current assets | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- | ---- | ---- | ---- |
| Total current assets | -11.77%6.73B | -10.14%7.53B | -11.08%7.99B | -14.10%7.9B | -23.58%7.63B | -18.71%8.37B | -18.54%8.99B | -23.24%9.2B | -22.73%9.98B | -15.42%10.3B |
| Non Current assets | ||||||||||
| Debt investment | -3.78%1.78B | -5.19%1.28B | 1.77%1.15B | -6.20%1.21B | 30.28%1.85B | -4.93%1.35B | -23.13%1.13B | 65.38%1.29B | 77.50%1.42B | 57.78%1.42B |
| Other non-current financial assets | 0.00%11.3M | 0.00%11.3M | 0.00%11.3M | 0.00%11.3M | 0.00%11.3M | 0.00%11.3M | 0.00%11.3M | 0.00%11.3M | 0.00%11.3M | 0.00%11.3M |
| Long-term equity investment | -69.20%219.98K | -69.20%219.98K | -39.64%431.06K | -39.64%431.06K | 0.00%714.18K | 0.00%714.18K | 0.00%714.18K | --714.18K | --714.18K | --714.18K |
| Fixed assets | ---- | ---- | ---- | 14.80%2.03B | ---- | 8.44%1.95B | ---- | 10.62%1.77B | ---- | 21.35%1.8B |
| Fixed assets liquidation | ---- | ---- | ---- | --190.79K | ---- | ---- | ---- | ---- | ---- | ---- |
| Constru in process | ---- | ---- | ---- | 2.45%1.41B | ---- | 80.34%1.47B | ---- | 77.09%1.38B | ---- | 13.05%814.56M |
| Intangible assets | 54.43%781.19M | 55.60%797.38M | 58.85%821.43M | 57.73%819.95M | -3.16%505.84M | 0.82%512.46M | -2.22%517.11M | -0.82%519.84M | 80.43%522.35M | 73.77%508.28M |
| Development expenditure | -6.55%199.8M | -17.37%165.58M | -73.54%44.62M | -89.92%16.71M | 46.50%213.8M | 49.04%200.4M | 92.37%168.62M | 113.94%165.75M | 129.35%145.94M | 237.17%134.46M |
| Long deferred expense | -0.47%157.58M | -22.42%126.81M | 131.87%166.46M | 120.53%163.87M | 105.98%158.33M | 104.74%163.45M | -40.74%71.79M | -40.12%74.31M | -41.20%76.87M | -39.75%79.83M |
| Deferred tax assets | 42.61%359.3M | 38.98%338.18M | 71.00%272.44M | 35.94%251.52M | 56.92%251.94M | 54.05%243.33M | 26.35%159.32M | 95.89%185.03M | 120.49%160.55M | 139.31%157.95M |
| Usufruct assets | -49.36%59.13M | -43.07%69.01M | 290.09%80.04M | 373.40%105.3M | 358.79%116.75M | 304.90%121.21M | -38.09%20.52M | -32.89%22.24M | -31.61%25.45M | -13.00%29.93M |
| Other non current assets | -12.91%248.06M | -4.75%280.67M | -15.20%371.81M | -9.06%312.06M | -39.77%284.84M | -35.86%294.67M | -14.05%438.45M | -26.62%343.17M | -29.60%472.92M | 23.40%459.41M |
| Total non current assets | 2.77%7.03B | 3.22%6.52B | 10.90%6.38B | 9.97%6.34B | 22.77%6.84B | 16.66%6.31B | 5.89%5.75B | 28.29%5.76B | 28.55%5.57B | 33.66%5.41B |
| Total assets | -4.90%13.76B | -4.39%14.04B | -2.50%14.37B | -4.82%14.24B | -6.98%14.47B | -6.53%14.69B | -10.48%14.74B | -9.19%14.96B | -9.84%15.56B | -3.17%15.71B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 28.34%147.57M | 28.99%133.66M | 23.51%120.59M | 39.15%120.16M | 41.48%114.99M | 27.71%103.62M | -10.27%97.64M | -33.56%86.35M | -45.86%81.27M | -42.10%81.14M |
| Notes payable and accounts payable | 11.45%452.28M | -6.50%415.94M | 9.39%470.8M | -14.08%373.8M | 12.17%405.8M | 14.19%444.86M | 39.50%430.38M | 41.41%435.06M | 7.43%361.77M | 10.74%389.59M |
| -Notes payable | 29.69%15.46M | -18.57%19.87M | -36.82%18.6M | 2.52%28.93M | -10.12%11.92M | -72.80%24.41M | -2.53%29.43M | -45.74%28.22M | -67.38%13.27M | 158.10%89.72M |
| -Accounts payable | 10.90%436.81M | -5.80%396.06M | 12.78%452.21M | -15.23%344.87M | 13.02%393.87M | 40.21%420.45M | 44.06%400.95M | 59.13%406.84M | 17.71%348.5M | -5.42%299.87M |
| Contract liabilities | -7.83%37.97M | -14.74%41.05M | 126.39%90.17M | 12.67%47.33M | 15.33%41.2M | -31.58%48.15M | -30.71%39.83M | -8.03%42M | 14.33%35.72M | -14.47%70.38M |
| Salaries payable | 1.76%108.18M | 10.00%199.24M | 8.23%169.49M | -2.26%136.91M | 0.06%106.31M | 4.39%181.13M | -31.16%156.61M | -30.28%140.08M | -34.66%106.24M | -33.70%173.51M |
| Taxs payable | 46.73%20.07M | -1.93%23.05M | -34.66%14.34M | -9.68%15.69M | -31.94%13.68M | 42.83%23.5M | 10.66%21.95M | -70.32%17.37M | -90.51%20.1M | -88.65%16.46M |
| Other payable (including interest and dividends) | -32.33%725.13M | -17.70%910.16M | -21.92%912.46M | -25.46%968.23M | -35.52%1.07B | -39.72%1.11B | -42.12%1.17B | -39.14%1.3B | -29.85%1.66B | -26.19%1.83B |
| -Other payable | ---- | ---- | ---- | -25.46%968.23M | ---- | -39.72%1.11B | ---- | -38.64%1.3B | ---- | -26.19%1.83B |
| Non current liabilities due within one year | 14.40%101.86M | -26.65%76.37M | 182.47%93.62M | 105.12%61.24M | -19.18%89.04M | 3.60%104.11M | 49.71%33.14M | 100.37%29.86M | 640.05%110.18M | 498.15%100.49M |
| Other current liabilities | 188.93%5M | 224.40%2.75M | 194.65%2.52M | 41.15%2.77M | 203.94%1.73M | -77.45%847.38K | 106.73%856.24K | 300.41%1.96M | -20.85%569.72K | 93.95%3.76M |
| Adjustment items of current assets | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total current liabilities | -13.35%1.6B | -10.43%1.8B | -3.85%1.87B | -15.87%1.73B | -22.44%1.84B | -24.64%2.01B | -29.48%1.95B | -29.07%2.05B | -27.44%2.38B | -23.39%2.67B |
| Current liabilities | ||||||||||
| Long term loan | -36.57%58.86M | 4.88%98.79M | -24.91%102.31M | -32.39%88.22M | -27.91%92.79M | -18.35%94.19M | 5.10%136.25M | 12.20%130.47M | 9.18%128.72M | 12.56%115.36M |
| Long term deferred income | 8.88%69.15M | 18.81%64.39M | 94.38%64.72M | 80.48%60.21M | 88.23%63.51M | 61.07%54.2M | -25.51%33.29M | -26.76%33.36M | -24.26%33.74M | -18.67%33.65M |
| Lease liabilities | -37.97%46.74M | -43.73%45.57M | 397.24%56.6M | 489.13%63.5M | 557.38%75.35M | 554.99%80.97M | -27.22%11.38M | -33.29%10.78M | -40.17%11.46M | -32.91%12.36M |
| Total non current liabilities | -24.57%174.75M | -8.99%208.75M | 23.60%223.62M | 21.37%211.92M | 33.20%231.65M | 42.14%229.36M | -12.08%180.93M | -10.85%174.61M | -12.59%173.92M | -10.07%161.37M |
| Adjustment items of total current liabilities | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total liabilities | -14.61%1.77B | -10.28%2.01B | -1.52%2.1B | -12.95%1.94B | -18.65%2.08B | -20.83%2.24B | -28.27%2.13B | -27.91%2.23B | -26.59%2.55B | -22.74%2.83B |
| Shareholders equity | ||||||||||
| Paid-in capital | -0.06%1.26B | -0.06%1.26B | 0.00%1.27B | -0.24%1.27B | -0.24%1.27B | -0.24%1.27B | -0.24%1.27B | 0.00%1.27B | 39.97%1.27B | 39.97%1.27B |
| Capital reserve funds | -2.91%3.05B | -2.91%3.05B | 0.00%3.14B | -5.90%3.14B | -5.22%3.14B | -5.22%3.14B | -5.64%3.14B | 0.54%3.34B | -11.18%3.31B | -11.18%3.31B |
| Surplus reserve funds | 0.00%718.54M | 0.00%718.54M | 6.48%718.54M | 6.48%718.54M | 6.48%718.54M | 6.48%718.54M | 22.84%674.79M | 22.84%674.79M | 22.84%674.79M | 22.84%674.79M |
| Retained profit | -5.41%6.79B | -5.51%6.83B | -5.08%7.06B | -4.60%7.09B | -6.77%7.18B | -4.53%7.23B | -9.98%7.44B | -8.88%7.43B | -10.48%7.7B | 2.96%7.57B |
| Less:Treasury stock | ---- | ---- | 0.00%92.17M | -41.87%92.17M | -33.89%92.17M | -28.78%92.17M | -4.99%92.17M | 72.03%158.56M | -30.35%139.42M | -35.34%129.42M |
| Shareholders equity without minority interests | -3.18%11.82B | -3.25%11.86B | -2.69%12.09B | -3.44%12.12B | -4.73%12.21B | -3.45%12.26B | -6.65%12.42B | -4.90%12.55B | -5.67%12.82B | 2.91%12.7B |
| Minority interests | -9.38%166.56M | -9.02%168.46M | -1.31%183.69M | -0.92%183.7M | -1.79%183.79M | 1.15%185.16M | -0.48%186.14M | -2.72%185.41M | -2.26%187.13M | -18.14%183.06M |
| Total shareholder equity | -3.27%11.99B | -3.33%12.03B | -2.67%12.27B | -3.41%12.3B | -4.69%12.39B | -3.38%12.45B | -6.56%12.61B | -4.87%12.74B | -5.62%13B | 2.54%12.88B |
| Total liabilityies and equity | -4.90%13.76B | -4.39%14.04B | -2.50%14.37B | -4.82%14.24B | -6.98%14.47B | -6.53%14.69B | -10.48%14.74B | -9.19%14.96B | -9.84%15.56B | -3.17%15.71B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Rongcheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rongcheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rongcheng Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On June 1 Eastern Time, Middle East geopolitics took a dramatic turn. Iran's Tasnim News Agency reported that, in light of Israel’s ongoing
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm